<!DOCTYPE html>
<html manifest="manifest.manifest">
<head>
	<meta http-equiv=Content-Type content="text/html; charset=utf-8">
	<title>MRCG Clinical Guidelines</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=2.0, user-scalable=1">
  
	<meta name=Generator content="Microsoft Word 14 (filtered)">
	<link rel="manifest" href="/manifest.json">	
<link rel="stylesheet" href="jquery.mobile-1.4.5.min.css" />
	<link rel="stylesheet" href="mystyle.css" />
	<script src="jquery-1.11.1.min.js"></script>
	<script src="jquery.mobile-1.4.5.min.js"></script>
	<script type="text/javascript" src="cordova.js"></script>
	<script>
	    		$(function(){
			$("[data-role='header'], [data-role='footer']").toolbar();
		});
  	  $(document).one('pagebeforecreate', function () {
	        $('input[data-type="search"]').val("");
	    	        $.get("panel.html", function (data2) {
            $.mobile.pageContainer.prepend(data2);
              $("[data-role=panel]").panel().enhanceWithin();
        }, "html");
	           $.get("header.html", function (data) {
      $.mobile.pageContainer.prepend(data);
      $("[data-role='header']").toolbar().enhanceWithin();
    }, "html");
    $.get("footer.html", function (data) {
      $.mobile.pageContainer.append(data);
      $("[data-role='footer']").toolbar().enhanceWithin();
    }, "html");
        $('.WordSection1').wrap('<div role="main" class="ui-content">');
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $.mobile.pageContainer.enhanceWithin();
	  });
	        $(document).bind( "pagechange", function( ) {
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $('.tableCont').enhanceWithin();
      } );
			// When the user scrolls down 20px from the top of the document, show the button
		window.onscroll = function() {scrollFunction()};
		function scrollFunction() {
		  if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
			document.getElementById("myBtn").style.display = "block";
		  } else {
			document.getElementById("myBtn").style.display = "none";
		  }
		}
		// When the user clicks on the button, scroll to the top of the document
		function topFunction() {
		  document.body.scrollTop = 0; // For Safari
		  document.documentElement.scrollTop = 0; // For Chrome, Firefox, IE and Opera
		}</script>      
	









  
  
  	
</head>
<body lang=EN-GB link=blue vlink=purple>
	
<div data-role="page">
	<div role="main" class="ui-content">
<div class=WordSection1>
<h1>Chronic obstructive pulmonary disease (COPD)</h1>
<h2><i><span lang=EN-US>Executive summary</span></i></h2>
<h2><span lang=EN-US>Introduction</span></h2>
<p class=MsoNormal>COPD is a chronic lung condition characterised by air-flow
limitation that is not fully reversible. It usually progresses over time –
either gradually or in a step-wise fashion. It is most commonly associated with
smoking, but may also be associated with cooking over wood fires, exposure to
dust or a history of TB.</p>
<p class=MsoNormal>COPD is not easy to diagnose. There is no single test and
the diagnosis will depend on a good history and examination. Tests are at best
suggestive of COPD. It is not curable but can be treated. Adequate treatment
can slow the rate of progression.</p>
<h2><span lang=EN-US>Target users</span></h2>
<p class=MsoListParagraphCxSpFirst style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Doctors</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Nurses</span></p>
<h2><span lang=EN-US>Target area of use </span></h2>
<p class=MsoListParagraphCxSpFirst style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Outpatients department</span></p>
<p class=MsoListParagraphCxSpLast style='margin-left:39.0pt;text-indent:-18.0pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Ward</span></p>
<h2><span lang=EN-US>Key areas of focus / New additions / Changes </span></h2>
<p class=MsoNormal><span lang=EN-US>This guideline outlines the diagnosis and
management of COPD in our setting.</span></p>
<h2><span lang=EN-US>Limitations</span></h2>
<p class=MsoNormal><span lang=EN-US>Diagnosis is difficult in the absence of
access to spirometry.</span></p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
lang=EN-US style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2>Diagnosis</h2>
<h3><span lang=EN-US>Presenting symptoms and signs</span></h3>
<p class=MsoNormal>Patients complain of shortness of breath on exertion, c<span
lang=EN-US>hronic cough, often productive of sputum, wheeze and recurrent chest
infections.</span></p>
<p class=MsoNormal>The exact degree of exertion required to bring on symptoms
will vary from patient to patient. Some patients will not experience much
shortness of breath but will have limited their activity levels to avoid
exertion. This leads to most patients being overweight – however, patients with
very severe disease can develop cachexia.</p>
<p class=MsoNormal>Most patients will give a history of smoking or other
environmental exposure. A few patients may have a history of asthma which has
evolved into COPD.</p>
<p class=MsoNormal>Symptoms commonly vary in severity over the day or from week
to week. They are most often worse in the mornings.</p>
<h3><span lang=EN-US>Examination findings</span></h3>
<p class=MsoNormal>Patients may be using their accessory respiratory muscles.
They may purse their lips on expiration. The lungs may be over-distended, with
very reduced air entry and a long expiratory phase. There may be wheeze on
auscultation. </p>
<p class=MsoNormal>Patients may have signs of right heart failure in
established disease. Mild ankle oedema may be seen even in the absence of heart
failure. Clubbing is not typical of COPD and suggests another diagnosis.</p>
<p class=MsoNormal>The saturations should be measured. Levels below 92% on air
are abnormal.</p>
<h3><span lang=EN-US>Investigation</span></h3>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Hb – anaemia commonly coexists with COPD and treatment can reduce
symptoms. </p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Blood glucose, renal profile and electrolytes are all useful to
exclude alternative causes of shortness of breath. If the renal function is
normal, but the bicarbonate is raised, this is an indication of chronic
under-ventilation. This is very important to note in hypoxic patients.</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Spirometry is not available here. PEFR can be measured instead,
but it often underestimates the degree of airflow obstruction in COPD. </p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Chest X-ray is important to exclude other diagnoses. About half
of patients with COPD have a normal X-ray. Features supportive of a diagnosis
of COPD are: increased radiolucency of the lung, flat diaphragm, long, narrow
heart shadow, bullae and evidence of right heart failure.</p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>ECG may show right axis deviation, incomplete right bundle branch
block, low voltage across all leads, persistent S waves in the precordial leads
or prominent peaked P waves in leads II, III and aVF.</p>
<span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br clear=all
style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
style='font-size:12.0pt'>&nbsp;</span></b></p>
<h2 style='margin-bottom:6.0pt'>Differential diagnoses</h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Bronchial Asthma</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Central airway obstruction may be caused by a malignancy or by TB
lymph nodes. </p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Bronchiectasis is very difficult to differentiate from COPD – it
is suggested by daily purulent sputum production. </p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Heart failure usually presents with a large heart on CXR along
with signs of pulmonary oedema.</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>TB usually causes consolidation or other CXR signs. However, it
can co-exist with COPD and about 30% of former TB patients will later develop
some degree of airflow obstruction.</p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Rarer lung diseases that can cause progressive shortness of
breath include pulmonary fibrosis and bronchiolitis obliterans.</p>
<h2 style='margin-bottom:6.0pt'>Management</h2>
<h3>Management in OPD</h3>
<p class=MsoNormal><i><span lang=EN-US>This is only for stable COPD</span></i></p>
<p class=MsoNormal>The management of COPD is difficult in our setting – we have
access neither to the investigations we need to guide treatment nor to the best
treatments.</p>
<p class=MsoNormal>The most important intervention is to encourage the patient
to avoid any possible causes of COPD. Smokers should be encouraged to stop and
women who cook over wood fires should try to avoid this.</p>
<p class=MsoNormal>Bronchodilators have been shown to improve symptoms and
exercise capacity. Short-acting bronchodilators such as salbutamol are best
administered via inhaler with a spacer. A spacer can be made from a plastic
bottle. They work quickly and are particularly helpful to patients with mild
intermittent symptoms. They are most effective and safest when used on an as-needed
basis. Salbutamol can be prescribed orally but is more likely to cause serious
side effects such as cardiac arrhythmias. As COPD is by definition not fully
reversible, the benefits may not outweigh the risks.</p>
<p class=MsoNormal>If further treatment is required long-acting bronchodilators
(either salmeterol or tiotropium) would be recommended next. Inhaled steroids,
if prescribed, should be given with these agents.</p>
<p class=MsoNormal>In the absence of access to bronchodilators, aminophylline
can be used. It is controversial, but there is some evidence of an improvement
in lung function and improved exercise tolerance. It is toxic in overdose.</p>
<p class=MsoNormal>Oral steroids have no place in the management of stable
COPD. </p>
<span lang=EN-US style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br
clear=all style='page-break-before:always'>
</span>
<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><u><span
lang=EN-US><span style='text-decoration:none'>&nbsp;</span></span></u></b></p>
<h3><span lang=EN-US>Management on the ward</span></h3>
<p class=MsoNormal><i><span lang=EN-US>Patients with exacerbations of COPD are
managed as inpatients on the ward.</span></i></p>
<p class=MsoNormal>Exacerbations are characterised by increase in cough,
increased sputum production and increased shortness of breath.</p>
<p class=MsoNormal>Note that 70% of exacerbations are thought to be caused by
infections (bacterial or viral). Most of the remaining cases are caused by
pulmonary emboli.</p>
<p class=MsoNormal>Patients with an exacerbation should be investigated with
saturations, chest X-ray (to exclude pneumonia, pneumothorax, pulmonary oedema
and pleural effusion), FBC, electrolytes, renal profile and glucose. Those with
hypoxia (saturations &lt; 92%) or who remain breathless after a nebuliser will
need admission to hospital. </p>
<p class=MsoNormal>All patients will benefit from inhaled salbutamol during an
acute exacerbation.</p>
<p class=MsoNormal>Oral steroids may help a little – give prednisolone 40 mg OD
for 5 days in outpatients. Courses can be extended to 14 days for those ill
enough to be admitted.</p>
<p class=MsoNormal>Patients who have 2 of these symptoms will benefit from
antibiotics</p>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>increased shortness of breath, </p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>increased sputum production, </p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>increased sputum purulence. </p>
<p class=MsoNormal>Those who are under age 65, without heart disease and who
have less than 3 exacerbations per year can be given azithromycin, doxycycline
or co-trimoxazole. Other patients should be treated with ciprofloxacin or
co-amoxiclav. The antibiotics should be cycled to prevent resistance –
especially in those receiving regular courses.</p>
<p class=MsoNormal>Oxygen should be used in all patients with saturations &lt; 88%.
It should be given via nasal prongs at an initial rate of 2 litres per minute
and increased up to a rate of 6 litres per minute if necessary. The aim is to
keep the saturations<sub> </sub>between 88 and 92%. Higher levels than this are
associated with hypercapnia and increased mortality.</p>
<h2>Key Issues for Nursing care</h2>
<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Check the O<sub>2 </sub>saturation. Provide oxygen via nasal
prongs if O<sub>2 </sub>saturation is less than 88% but do not allow to be more
than 92%.</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Give salbutamol nebuliser if very short of breath.</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Sit patient upright – in the acute phase they will be most
comfortable sitting with their arms resting on a pillow on a table. This
position provides the most support to the intercostal muscles.</p>
<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Encourage mobilisation.</p>
<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Give patient advice to discontinue smoking and/or avoid cooking
over an open wood fire.</p>
<p class=MsoNormal><b><span lang=EN-US>References</span></b></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Han, Dransfield
and Martinez 2017. Chronic obstructive pulmonary disease: Disease, clinical
manifestations, diagnosis, and staging. UpToDate Aug 2017.</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Ferguson and Make
2017. Management of stable chronic obstructive pulmonary disease. UpToDate June
2017</span></p>
<p class=MsoNormal><span lang=EN-US style='font-size:10.0pt'>Stoller 2017. Management
of exacerbations of chronic obstructive pulmonary disease. UpToDate Aug 2017.</span></p>
<div class="tableCont">
  <table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Written by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Babatunde Awokola</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 2 July 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Reviewed by:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Name: Karen Forrest</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Date: 25 July 2018</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Version:</span></b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Change history:</span></b></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>Review due date:</span></b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>1.0</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>New document</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>2.0</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Transferred to new template</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 July 2020</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>2.1</span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Executive summary added</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>31 July 2020</span></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>Review Comments (<i>if applicable)</i></span></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
  lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
  lang=EN-US>&nbsp;</span></b></p>
  </td>
 </tr>
</table>
</div>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
<p class=MsoNormal><span lang=EN-US>&nbsp;</span></p>
</div>
</div><!-- /content -->

</div>

</body>
</html>
